NO20000513L - Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav - Google Patents

Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav

Info

Publication number
NO20000513L
NO20000513L NO20000513A NO20000513A NO20000513L NO 20000513 L NO20000513 L NO 20000513L NO 20000513 A NO20000513 A NO 20000513A NO 20000513 A NO20000513 A NO 20000513A NO 20000513 L NO20000513 L NO 20000513L
Authority
NO
Norway
Prior art keywords
hiv
methods
effective detection
transcription primers
oligonucleotide transcription
Prior art date
Application number
NO20000513A
Other languages
English (en)
Other versions
NO20000513D0 (no
NO327727B1 (no
Inventor
David R Patterson
John A Puskas
Keming Song
Jeffrey M Linnen
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of NO20000513D0 publication Critical patent/NO20000513D0/no
Publication of NO20000513L publication Critical patent/NO20000513L/no
Publication of NO327727B1 publication Critical patent/NO327727B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO20000513A 1999-02-02 2000-02-01 Fremgangsmate for revers transkribering og deteksjon av HIV-RNA i en biologisk prove, oligonukleotid og kit. NO327727B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11841799P 1999-02-02 1999-02-02

Publications (3)

Publication Number Publication Date
NO20000513D0 NO20000513D0 (no) 2000-02-01
NO20000513L true NO20000513L (no) 2000-08-03
NO327727B1 NO327727B1 (no) 2009-09-14

Family

ID=22378462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000513A NO327727B1 (no) 1999-02-02 2000-02-01 Fremgangsmate for revers transkribering og deteksjon av HIV-RNA i en biologisk prove, oligonukleotid og kit.

Country Status (13)

Country Link
US (1) US6303293B1 (no)
EP (1) EP1026263B1 (no)
JP (1) JP2000342274A (no)
KR (1) KR100901084B1 (no)
CN (1) CN1186455C (no)
AT (1) ATE397099T1 (no)
AU (1) AU761066B2 (no)
CA (1) CA2295920C (no)
DE (1) DE60038993D1 (no)
DK (1) DK1026263T3 (no)
ES (1) ES2306648T3 (no)
NO (1) NO327727B1 (no)
PT (1) PT1026263E (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8036741B2 (en) 1996-04-30 2011-10-11 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6479523B1 (en) * 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
AU779255B2 (en) 1999-06-25 2005-01-13 Emory University Devices and methods for vagus nerve stimulation
DE60041489D1 (de) * 1999-07-09 2009-03-19 Gen Probe Inc Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
WO2002034951A2 (en) * 2000-10-23 2002-05-02 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
ATE549421T1 (de) * 2003-12-19 2012-03-15 Gen Probe Inc Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
CN100340673C (zh) * 2005-02-03 2007-10-03 上海科华生物工程股份有限公司 人类免疫缺陷病毒hiv－1核酸扩增－荧光定量检测试剂盒
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8423134B2 (en) 2010-04-29 2013-04-16 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
WO2013111800A1 (ja) 2012-01-25 2013-08-01 独立行政法人科学技術振興機構 Ｈｉｖ検出用オリゴヌクレオチド、ｈｉｖ検出キット、及びｈｉｖ検出方法
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3149203B1 (en) 2014-05-27 2019-12-04 Université Paris Descartes In vitro method for the detection and quantification of hiv-2
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
AU2017301881A1 (en) * 2016-07-29 2019-02-07 Juno Therapeutics, Inc. Methods for assessing the presence or absence of replication competent virus
JP7203017B2 (ja) * 2016-09-07 2023-01-12 セイント ヴィンセンツ ホスピタル シドニー リミテッド レンチウイルスを検出する方法
CN106498095A (zh) * 2016-11-14 2017-03-15 湖南圣湘生物科技有限公司 一种人类免疫性缺陷病毒2型核酸检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2685262A1 (fr) 1989-06-02 1990-12-13 Institut National De La Sante Et De La Recherche Medicale Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
US5478724A (en) 1991-08-16 1995-12-26 The Rockefeller University Lentivirus-specific nucleotide probes and methods of use
DE59309207D1 (de) 1992-10-06 1999-01-21 Dade Behring Marburg Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
US6303293B1 (en) 2001-10-16
NO20000513D0 (no) 2000-02-01
EP1026263A2 (en) 2000-08-09
ES2306648T3 (es) 2008-11-16
CN1186455C (zh) 2005-01-26
DK1026263T3 (da) 2008-09-08
CN1271020A (zh) 2000-10-25
EP1026263B1 (en) 2008-05-28
KR20010014470A (ko) 2001-02-26
CA2295920A1 (en) 2000-08-02
AU1482900A (en) 2000-08-03
KR100901084B1 (ko) 2009-06-08
PT1026263E (pt) 2008-08-27
CA2295920C (en) 2013-10-29
NO327727B1 (no) 2009-09-14
ATE397099T1 (de) 2008-06-15
EP1026263A3 (en) 2000-10-11
AU761066B2 (en) 2003-05-29
JP2000342274A (ja) 2000-12-12
DE60038993D1 (de) 2008-07-10

Similar Documents

Publication Publication Date Title
NO20000513L (no) Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
NO20000536L (no) Oligonucleotide primere for effektiv detektering av Hepatitt C-virus (HCV) og metoder for anvendelse derav
FR16C0028I1 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
DE60041489D1 (de) Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
DK1313462T3 (da) Anvendelse af asiatisk syre eller asiaticosid til behandling af cancer
ATE386821T1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
NO20000514D0 (no) Oligonukleotidprimere for effektiv multipleks deteksjon av Hepatitis C-virus (HCV) og human immunmangelvirus (HIV) og metoder for anvendelse derav
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
WO2002022076A3 (en) Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
WO2002099387A3 (en) Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
WO2001027330A3 (en) Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
FR2834717B1 (fr) Mutants de la proteine tat du virus vih-1
WO2004016228A3 (en) HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS
DE69426574T2 (de) Makrocyclische difluorostatonderivate als antivirale mittel
CY1108543T1 (el) Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees